pt141 nausea What Foods and Drinks Are Consumed Less by Those on GLP-1 Weight-Loss Meds? GLP-1 agonists pose emerging challenge

Research shows its safe and effective

5 The annual incidence ranges from 8.8 to 23.1 per 100,000 person-years in North America, 0.624.3 per 100,000 person-years in Europe, and 7.317.4 per 100,000 person-years in Oceania, with a prevalence in adults in their 30 s and 40 s

The claim that building habits during the drug window improves long-term outcomes is well-supported by the biological logic and general behavioral research, but hasn't been tested in large-scale GLP-1 RCTs

doi: 10.3389/fendo.2025.1572997 Received 08 February 2025 Accepted 25 June 2025 Published 10 July 2025 Volume 16 - 2025 Edited by Terry Francis Davies, Icahn School of Medicine at Mount Sinai, United States Reviewed by Morteza Gholami, Golestan University, Iran Lucia Acampora, University of Naples Federico II, Italy Updates Copyright 2025 Cui, Wang, Li, Liu, Wang and Zhao